Brett Kavanaugh with Sen. Lisa Murkowski. Photo: Chip Somodevilla/Getty Images

With just two months until the 2018 election, the GOP is taking the Supreme Court fight to voters ahead of the midterms.

The state of play: The Republican National Committee (RNC) is launching a six-figure digital ad buy today directing people to a new website loaded with facts and press about Brett Kavanaugh. They hope to encourage voters to contact their Democratic senators about confirming him.

Why it matters: The final stretch before the midterm election is the most consequential time to get voters motivated to actually show up to the polls. Republicans believe this could be a winning issue for them in November, especially in the Senate.

  • In 2016, 26% of Trump voters said Supreme Court nominees were the most important factor in their 2016 vote, according to exit polls.
  • The primary emphasis of their digital ads will be in the 10 states President Trump won in 2016 that have a Democratic senator up for re-election.

The RNC — in coordination with the White House, Capitol Hill, and outside GOP groups — has already been going all-in on using Kavanaugh to rev up their base.

  • They immediately sent out digital emails and posts about him just minutes after Trump announced his nomination.
  • They've been on the airwaves with Kavanaugh-specific messaging and have incorporated SCOTUS picks into their scripts when knocking on doors.

What they're saying: "We’re going to make sure the American people know about the Democrats’ unprecedented level of resistance" to Kavanaugh, RNC Chairwoman Ronna McDaniel told Axios in a statement.

The bottom line: The GOP knows it needs every vote it can get to confirm Kavanaugh. If he's not confirmed, you'll likely hear a lot more from the GOP about "obstructionist Democrats" who are leading the "resistance."

Go deeper

Updated 4 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 10 p.m. EST: 32,135,220 — Total deaths: 981,660 — Total recoveries: 22,149,441Map.
  2. U.S.: Total confirmed cases as of 10 p.m EST: 6,975,980 — Total deaths: 202,738 — Total recoveries: 2,710,183 — Total tests: 98,481,026Map.
  3. Politics: House Democrats prepare new $2.4 trillion coronavirus relief package.
  4. Health: Cases are surging again in 22 states — New York will conduct its own review of coronavirus vaccine.
  5. Business: America is closing out its strongest quarter of economic growth.
  6. Technology: 2020 tech solutions may be sapping our resolve to beat the pandemic.
  7. Sports: Pac-12 will play this fall despite ongoing pandemic — Here's what college basketball will look like this season.
  8. Science: Global coronavirus vaccine initiative launches without U.S. or China — During COVID-19 shutdown, a common sparrow changed its song.
7 hours ago - Sports

Pac-12 will play football this fall, reversing course

A view of Levi's Stadium during the 2019 Pac-12 Championship football game. Photo: Alika Jenner/Getty Images

The Pac-12, which includes universities in Arizona, California, Colorado, Oregon, Utah and Washington state, will play football starting Nov. 6, reversing its earlier decision to postpone the season because of the coronavirus pandemic.

Why it matters: The conference's about-face follows a similar move by the Big Ten last week and comes as President Trump has publicly pressured sports to resume despite the ongoing pandemic. The Pac-12 will play a seven-game conference football season, according to ESPN.

Dave Lawler, author of World
8 hours ago - World

Global coronavirus vaccine initiative launches without U.S. or China

Data: Gavi, The Vaccine Alliance; Map: Naema Ahmed/Axios

A global initiative to ensure equitable distribution of coronavirus vaccines now includes most of the world — but not the U.S., China or Russia.

Why it matters: Assuming one or more vaccines ultimately gain approval, there will be a period of months or even years in which supply lags far behind global demand. The COVAX initiative is an attempt to ensure doses go where they're most needed, rather than simply to countries that can produce or buy them at scale.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!